Last Updated IST
Representative image. Credit: iStock Photo
India's first mRNA vaccine HGCO19 received DCGI nod for Phase II/III clinical trials on Tuesday. The Covid-19 vaccine has been developed by Gennova Biopharmaceuticals Ltd, a Pune-based biotechnology company in partnership with the Department of Biotechnology.
More to follow...
Deccan Herald is on WhatsApp Channels | Join now for Breaking News & Editor's Picks